NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: M
Post# of 174

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, recently announced its uplisting to the Nasdaq Capital Market and rang the opening bell on Friday, Feb. 28, 2020. An article discussing the company reads, “‘We’ve been under the radar for a long time. We’re trying to create visibility among the investor base by doing the right thing,’ CEO Suren Ajjarapu stated late last year following completion of an agreement between its subsidiary Bonum Health and Benzer Pharmacy to create a network of ‘Bonum Health Hub’ units in small towns and rural areas as part of the lead-up to the Nasdaq listing (http://nnw.fm/S6Nai). . . . The company recently completed a firm-commitment public offering of 806,452 shares of its common stock following a voter-approved reverse stock split. Trxade expects to gain gross proceeds of $5.2 million from the sale of common stock in the offering, minus standard expenses tied to the offering.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

